Home › Thrombocytopenia › California
Thrombocytopenia clinical trials in California
3 studies for Thrombocytopenia are looking for participants at sites in California.
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235Neonatal Platelet Transfusion Threshold Trial
- Stanford University, Palo Alto
- Sharp Mary Birch Hospital for Women & Newborns, San Diego
RecruitingHealthy volunteers welcome
1 Hour – 48 Hours · All sexes · Updated Mar 25, 2026 · NCT06676904A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- City of Hope - Duarte Main Site, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT05980806From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.